Clinical Trials Related to Novo Nordisk A/S

Related studies linked through entity extraction aliases.

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

Status: COMPLETED
Phase: PHASE1

Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia

Status: COMPLETED
Phase: PHASE1

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months

Status: COMPLETED
Phase: N/A

Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

Status: UNKNOWN
Phase: PHASE4

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide

Status: COMPLETED
Phase: N/A

Observational Study on Safety of Self-titration of Once Daily Levemir®

Status: COMPLETED
Phase: N/A

An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes

Status: COMPLETED
Phase: N/A

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

Status: COMPLETED
Phase: N/A

Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

Status: COMPLETED
Phase: N/A

Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

Status: COMPLETED
Phase: N/A

Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers

Status: WITHDRAWN
Phase: PHASE1

Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes

Status: COMPLETED
Phase: PHASE3

Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Status: COMPLETED
Phase: PHASE1

Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir

Status: COMPLETED
Phase: PHASE4

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

Status: COMPLETED
Phase: N/A

Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Status: COMPLETED
Phase: PHASE2

Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes

Status: COMPLETED
Phase: N/A

Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

Status: COMPLETED
Phase: N/A

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Status: COMPLETED
Phase: PHASE3

Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes

Status: COMPLETED
Phase: N/A